Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/17/24 → 1/17/26 |
Funding
- Caribou Biosciences Incorporated: $63,977.00
23-MYEL-20-CB-PMC: A Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (CaMMouflage Trial)
- Monohan, Gregory (PI)